Long COVID Trial, Recruiting NCT06876948 Sponsor: Azienda Ospedaliero, Universitaria Pisana Condition: Long COVID
Back to Long Covid

Long COVID Trial, Recruiting

NCT06876948
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children and young people between 6 years old and 16 years and 11 months old
  • People who have had a confirmed COVID-19 infection and, at least 3 months later, are still experiencing — or have developed new — neurological symptoms such as fatigue, headaches, sleep problems, memory or thinking difficulties, mood changes, dizziness, muscle weakness, muscle pain, reduced sense of smell or taste, hearing loss, ringing in the ears, or other sensory problems, and these symptoms have lasted for at least 2 months with no other clear explanation
  • The parent or guardian (and the patient themselves, where appropriate) must be willing to sign a consent form agreeing to take part

Who may not be able to join:

  • People who do not have a good enough understanding of Italian, or who have communication difficulties that would make it hard to complete thinking and memory tests
  • People who would need sedation (medication to make them sleepy or calm) in order to have a 7 Tesla brain MRI scan
  • People who had a neurological or psychiatric condition that was diagnosed before their COVID-19 diagnosis
  • People whose parent or guardian is unwilling or unable to sign the consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +050 995995

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Azienda Ospedaliero, Universitaria Pisana
Registry
ClinicalTrials.gov
Start date
29 March 2023
Est. completion
29 March 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Changes in cognitive and neuropsychological functions in children and adolescents with Long COVID between T0 and T1.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov